The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Developmental Therapeutics Branch (DTB), DNA Replication Group, and the Laboratory of Cancer Biology & Genetics (LCBG) require one (1) Brand Name or Equal Diagenode Bioruptor Pico and one (1) Diagenode Bioruptor Plus (Sonicators).

This is a Combined Synopsis/Solicitation for commercial items, prepared in accordance with the format in FAR 12.6 as supplemented with additional information included in this notice, and shall be processed in accordance with FAR Part 13 – Simplified Acquisition Procedures.This announcement constitutes the only solicitation that will be provided in relation to the stated need contained herein. This solicitation is a request for quote (RFQ) and includes applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2021-05 (03/10/2021).

This requirement is a being conducted under North American Industry Classification Code (NAICS) 334516 (Analytical Laboratory Instrument Manufacturing) for which the small business size standard is 1,000 employees. One Firm-Fixed-Priced award is anticipated to be made in relation to this solicitation.

*** REFER TO THE ATTACHED DOCUMENT FOR ADDITIONAL DETAILS INCLUDING STATEMENT OF NEED (SON), APPLICABLE CLAUSES AND PROVISIONS, SUBMISSION INSTRUCTIONS, AND EVALUATION CRITERIA.***